Source: International Journal of Molecular Sciences. Unidades: FM, FCF
Subjects: MELANOMA, PROTEÍNAS QUINASES
ABNT
SOUZA, Laura Francisca Leite do Prado de et al. Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib. International Journal of Molecular Sciences, v. 26, p. 1-23, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms26062675. Acesso em: 22 maio 2025.APA
Souza, L. F. L. do P. de, Ferraz, L. S., Tortelli Junior, T. C., Ribeiro, C. A. J., Amaral, D. T., Arruda, D. C., et al. (2025). Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib. International Journal of Molecular Sciences, 26, 1-23. doi:10.3390/ijms26062675NLM
Souza LFL do P de, Ferraz LS, Tortelli Junior TC, Ribeiro CAJ, Amaral DT, Arruda DC, Oliveira EA de, Chammas R, Maria-Engler SS, Rodrigues T. Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-23.[citado 2025 maio 22 ] Available from: https://dx.doi.org/10.3390/ijms26062675Vancouver
Souza LFL do P de, Ferraz LS, Tortelli Junior TC, Ribeiro CAJ, Amaral DT, Arruda DC, Oliveira EA de, Chammas R, Maria-Engler SS, Rodrigues T. Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-23.[citado 2025 maio 22 ] Available from: https://dx.doi.org/10.3390/ijms26062675